Utility values in diabetic kidney disease: a literature review

References

• National Kidney Foundation (NKF). KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49(Suppl 2):S10-179
   Web of Science ®Google Scholar
• National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis 2012;60:850-86
   PubMed Web of Science ®Google Scholar
• Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8
   PubMed Web of Science ®Google Scholar
• Radbill B, Murphy B, LeRoith D. Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clin Proc 2008;83:1373-81
   PubMed Web of Science ®Google Scholar
• Adler AI, Stevens RJ, Manley SE, et al; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32
   PubMed Web of Science ®Google Scholar
• Atkins RC, Zimmet P. International Society of Nephrology/International Federation of Kidney Foundations World Kidney Day Steering Committee and the International Diabetes Federation. Diabetic kidney disease: act now or pay later. Am J Med Sci 2010;339:102-4
   Google Scholar
• International Diabetes Federation. Diabetes Atlas, 6th edn. 2013. Available at: http://www.diabetesatlas.org/content/foreword-0 (Last accessed 2 February 2014)
   Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005
   Google Scholar
• Arnold D, Girling A, Stevens A, Lilford R. Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. BMJ 2009;339:b2688
   PubMed Web of Science ®Google Scholar
• Morimoto T, Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol 2002;12:160-78
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis 2009;53(3 Suppl 3):S4-16
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Wittenborn JS, Segel JE, et al; Centers for Disease Control and Prevention CKD Initiative. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis 2010;55:452-62
   Google Scholar
• Smolen L, Klein T, Voelker J, Boye M. Economic benefits of slowing progress to end stage renal disease (ESRD) in patients with diabetes-related chronic kidney disease (DKD), compared with standard of care (SOC). Poster PUK17 presented at the ISPOR 17th Annual International Meeting, Washington DC, 2–6 June 2012
   Google Scholar
• Dale PL, Hutton J, Elgazzar H. Utility of health states in chronic kidney disease: a structured review of the literature. Curr Med Res Opin 2008;24:193-206
   PubMed Web of Science ®Google Scholar
• Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 2012;9:e1001307
   PubMed Web of Science ®Google Scholar
• Lung TW, Hayes AJ, Hayen A, et al. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res 2011;20:1669-78
   PubMed Web of Science ®Google Scholar
• Anees M, Hameed F, Mumtaz A, et al. Dialysis-related factors affecting quality of life in patients on hemodialysis. Iran J Kidney Dis 2011;5:9-14
   PubMed Web of Science ®Google Scholar
• Østhus TB, von der Lippe N, Ribu L, et al. Health-related quality of life and all-cause mortality in patients with diabetes on dialysis. BMC Nephrol 2012;13:78
   PubMed Web of Science ®Google Scholar
• Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol 2009;4:1293-301
   PubMed Web of Science ®Google Scholar
• Grandy S, Fox KM; SHIELD Study Group. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health Qual Life Outcomes 2012;10:99
   PubMed Web of Science ®Google Scholar
• Sureshkumar KK, Patel BM, Markatos A, et al. Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease. Clin Transplant 2006;20:19-25
   PubMed Web of Science ®Google Scholar
• Javanbakht M, Abolhasani F, Mashayekhi A, et al. Health related quality of life in patients with type 2 diabetes mellitus in Iran: a national survey. PLoS One 2012;7:e44526
   PubMed Web of Science ®Google Scholar
• Morgan CL, McEwan P, Morrissey M, et al. Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabet Med 2006;23:1100-5
   PubMed Web of Science ®Google Scholar
• O’Reilly DJ, Xie F, Pullenayegum E, et al. Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Qual Life Res 2011;20:939-43
   PubMed Web of Science ®Google Scholar
• Sakamaki H, Ikeda S, Ikegami N, et al. Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value Health 2006;9:47-53
   PubMed Web of Science ®Google Scholar
• Sakthong P, Charoenvisuthiwongs R, Shabunthom R. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health Qual Life Outcomes 2008;6:71
   PubMed Web of Science ®Google Scholar
• Zhang P, Brown MB, Bilik D, et al. Health utility scores for people with type 2 diabetes in US managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35:2250-6
   PubMed Web of Science ®Google Scholar
• Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238-43
   PubMed Web of Science ®Google Scholar
• Ahola AJ, Saraheimo M, Forsblom C, et al; FinnDiane Study Group. Health-related quality of life in patients with type 1 diabetes – association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant 2010;25:1903-8
   PubMed Web of Science ®Google Scholar
• Huang ES, Brown SE, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007;30:2478-83
   PubMed Web of Science ®Google Scholar
• Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model. Am J Kidney Dis 1998;31:794-802
   PubMed Web of Science ®Google Scholar
• Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2008;11:733-41
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal, April 2013. Available at: http://publications.nice.org.uk/pmg9 (Last accessed 25 June 2014)
   Google Scholar